Gray/White Matter Contrast in Parkinson’s Disease

Gray/White Matter Contrast in Parkinson’s Disease

Gray/white matter contrast (GWC) decreases with aging and has been found to be a useful MRI biomarker in Alzheimer’s disease (AD), but its utility in Parkinson’s disease (PD) patients has not been investigated. The aims of the study were to test whether GWC is sensitive to aging changes in PD patien...

Full description

Bibliographic Details
Main Authors: Carme Uribe, Barbara Segura, Hugo C. Baggio, Alexandra Abos, Anna I. Garcia-Diaz, Anna Campabadal, Maria J. Marti, Francesc Valldeoriola, Yaroslau Compta, Nuria Bargallo, Carme Junque
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Aging Neuroscience
Subjects:
Parkinson’s disease
gray/white matter contrast
cortical thickness
aging
magnetic resonance imaging
Online Access:http://journal.frontiersin.org/article/10.3389/fnagi.2018.00089/full

Internet

http://journal.frontiersin.org/article/10.3389/fnagi.2018.00089/full

Similar Items